The survey, conducted April 17-23, polled a nationally representative sample of 1,171 adults. KFF asked respondents to share their views on nine different policy actions to lower high drug costs.
A majority of respondents favored every policy action except one, which called for patients to pay a larger share if they choose a high-cost drug over a similar, cheaper version, according to the survey.
Here is a breakdown of public support for each action policy by political party.
1. Allowing the federal government to negotiate with drug companies to get a lower price on medications for Medicare recipients
Democrats: 96 percent
Republicans: 92 percent
Independents: 92 percent
2. Making it easier for generic drugs to enter the market to increase competition and reduce costs
Democrats: 84 percent
Republicans: 91 percent
Independents: 91 percent
3. Requiring drug companies to release information on pricing practices to the public
Democrats: 84 percent
Republicans: 84 percent
Independents: 88 percent
4. Limiting the amount drug companies can charge for high-cost treatments, such as hepatitis or cancer drugs
Democrats: 78 percent
Republicans: 79 percent
Independents: 79 percent
5. Creating an independent group that oversees the pricing of prescription drugs
Democrats: 74 percent
Republicans: 71 percent
Independents: 74 percent
6. Allowing Americans to buy prescription drugs imported from Canada
Democrats: 66 percent
Republicans: 75 percent
Independents: 77 percent
7. Allowing Americans to buy prescription drugs from online pharmacies based in Canada
Democrats: 73 percent
Republicans: 59 percent
Independents: 68 percent
8. Eliminating prescription drug ads
Democrats: 59 percent
Republicans: 53 percent
Independents: 59 percent
9. Encouraging people to buy cheaper drugs by requiring them to pay a higher share if they choose a similar, higher cost drug
Democrats: 40 percent
Republicans: 57 percent
Independents: 60 percent
More articles on supply chain:
Poll: GOP prioritizes lower drug prices over reducing government’s role in healthcare
10 most-read supply chain stories in Apri
Supply chain tip of the week: Target services — not supplies — for cost savings
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
